BioLife Solutions, Inc. Earnings Per Share, Basic and Diluted
BioLife Solutions, Inc. (BLFS) reported Earnings Per Share, Basic and Diluted of -$0.09 per share for the 12-month period ending 2019-12-31, per its 10-K filed 2020-05-15.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2020-05-15
- BioLife Solutions, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.03, a 103.85% decline year-over-year.
- BioLife Solutions, Inc. earnings per share, basic and diluted for the quarter ending 2020-03-31 was $0.87.
- BioLife Solutions, Inc. earnings per share, basic and diluted for the quarter ending 2018-03-31 was -$0.01.
- BioLife Solutions, Inc. earnings per share, basic and diluted for the quarter ending 2017-12-31 was -$0.05.
- BioLife Solutions, Inc. earnings per share, basic and diluted for fiscal 2019 was -$0.09.
- BioLife Solutions, Inc. earnings per share, basic and diluted for fiscal 2018 was -$1.56.
- BioLife Solutions, Inc. earnings per share, basic and diluted for fiscal 2017 was -$0.21.
- BioLife Solutions, Inc. earnings per share, basic and diluted for fiscal 2016 was -$0.54.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | -$0.23 derived: net income ÷ weighted average shares · filed 2024-02-29 | |||||||
| 2021-03-31 | -$0.03 derived: net income ÷ weighted average shares · filed 2022-05-10 | |||||||
| 2020-12-31 | $0.07 derived: net income ÷ weighted average shares · filed 2023-03-31 | |||||||
| 2020-03-31 | $0.87 derived: net income ÷ weighted average shares · filed 2021-05-17 | |||||||
| 2019-12-31 | -$0.09 10-K · filed 2020-05-15 | |||||||
| 2018-12-31 | -$1.56 10-K · filed 2020-05-15 | |||||||
| 2018-03-31 | -$0.01 10-Q · filed 2018-05-11 | $0.29 derived: net income ÷ weighted average shares · filed 2020-05-15 | $0.27 derived: net income ÷ weighted average shares · filed 2020-05-15 | $0.21 derived: net income ÷ weighted average shares · filed 2020-05-15 | ||||
| 2017-12-31 | -$0.05 derived: net income ÷ weighted average shares · filed 2019-03-15 | -$0.08 derived: net income ÷ weighted average shares · filed 2019-03-15 | -$0.14 derived: net income ÷ weighted average shares · filed 2019-03-15 | -$0.21 10-K · filed 2018-03-09 | ||||
| 2017-09-30 | -$0.03 10-Q · filed 2017-11-09 | -$0.09 derived: net income ÷ weighted average shares · filed 2018-11-08 | -$0.16 10-Q · filed 2017-11-09 | -$0.41 derived: net income ÷ weighted average shares · filed 2018-11-08 | ||||
| 2017-06-30 | -$0.06 10-Q · filed 2017-08-11 | -$0.13 10-Q · filed 2017-08-11 | -$0.38 derived: net income ÷ weighted average shares · filed 2018-08-09 | -$0.46 derived: net income ÷ weighted average shares · filed 2018-08-09 | ||||
| 2017-03-31 | -$0.07 10-Q · filed 2018-05-11 | -$0.32 derived: net income ÷ weighted average shares · filed 2018-05-11 | -$0.40 derived: net income ÷ weighted average shares · filed 2018-05-11 | |||||
| 2016-12-31 | -$0.26 derived: net income ÷ weighted average shares · filed 2018-03-09 | -$0.34 derived: net income ÷ weighted average shares · filed 2018-03-09 | -$0.54 10-K · filed 2018-03-09 | |||||
| 2016-09-30 | -$0.08 10-Q · filed 2017-11-09 | -$0.28 10-Q · filed 2017-11-09 | ||||||
| 2016-06-30 | -$0.11 10-Q · filed 2017-08-11 | -$0.21 10-Q · filed 2017-08-11 | ||||||
| 2016-03-31 | -$0.10 10-Q · filed 2017-05-12 | |||||||
| 2015-12-31 | -$0.35 10-K · filed 2017-03-15 | |||||||
| 2015-09-30 | -$0.09 10-Q · filed 2016-11-10 | -$0.26 10-Q · filed 2016-11-10 | ||||||
| 2015-06-30 | -$0.08 10-Q · filed 2016-08-11 | -$0.17 10-Q · filed 2016-08-11 | ||||||
| 2015-03-31 | -$0.09 10-Q · filed 2016-05-16 | |||||||
| 2014-12-31 | -$0.31 10-K · filed 2016-02-25 | |||||||
| 2014-09-30 | -$0.07 10-Q · filed 2015-11-16 | -$0.23 10-Q · filed 2015-11-16 | ||||||
| 2014-06-30 | -$0.07 10-Q · filed 2015-08-06 | -$0.16 10-Q · filed 2015-08-06 | ||||||
| 2014-03-31 | -$0.10 10-Q · filed 2015-05-07 | |||||||
| 2013-12-31 | -$0.22 10-K · filed 2015-03-12 | |||||||
| 2013-09-30 | -$0.06 10-Q · filed 2014-11-06 | $0.00 10-Q · filed 2013-11-14 | -$0.12 10-Q · filed 2014-11-06 | -$0.01 10-Q · filed 2013-11-14 | ||||
| 2013-06-30 | -$0.06 10-Q · filed 2014-08-07 | $0.00 10-Q · filed 2013-08-12 | -$0.06 10-Q · filed 2014-08-07 | $0.00 10-Q · filed 2013-08-12 | ||||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-08 | |||||||
| 2012-12-31 | -$0.33 10-K · filed 2014-02-12 | -$0.02 10-K · filed 2013-03-29 | ||||||
| 2012-09-30 | -$0.01 10-Q · filed 2013-11-14 | -$0.02 10-Q · filed 2013-11-14 | ||||||
| 2012-06-30 | -$0.01 10-Q · filed 2013-08-12 | -$0.01 10-Q · filed 2013-08-12 | ||||||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-14 | |||||||
| 2011-12-31 | -$0.03 10-K · filed 2013-03-29 | |||||||
| 2011-09-30 | -$0.01 10-Q · filed 2012-11-13 | -$0.02 10-Q · filed 2012-11-13 | ||||||
| 2011-06-30 | -$0.01 10-Q · filed 2012-08-14 | -$0.02 10-Q · filed 2012-08-14 | ||||||
| 2011-03-31 | -$0.01 10-Q · filed 2012-05-14 | |||||||
| 2010-12-31 | -$0.03 10-K · filed 2012-03-29 | |||||||
| 2010-09-30 | -$0.01 10-Q · filed 2011-11-14 | -$0.02 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |